Results 21 to 30 of about 40,011 (243)
Objective: To evaluate the performance of interferon gamma release assays and tuberculin skin test in Bacillus Calmette-Guerin vaccinated young children.
Keswadee Lapphra +8 more
doaj +1 more source
Risk stratification of latent tuberculosis defined by combined interferon gamma release assays. [PDF]
BACKGROUND: Most individuals infected with Mycobacterium tuberculosis develop latent tuberculosis infection (LTBI). Some may progress to active disease and would benefit from preventive treatment yet no means currently exists to predict who will ...
Véronique Corbière +8 more
doaj +1 more source
Interferon-gamma release assay: use and misuse [PDF]
Interferon-gamma release assays are being increasingly used worldwide for the diagnosis of latent tuberculosis (TB) in patients of all ages, including children [1]. A PubMed search with ‘interferon-gamma release assays’ as keyword revealed a total of 1077 references, up to 100 of which had been released in 2012, including several reviews.
Brouqui, P. +3 more
openaire +2 more sources
TB screening in Canadian health care workers using interferon-gamma release assays. [PDF]
While many North American healthcare institutions are switching from Tuberculin Skin Test (TST) to Interferon-gamma release assays (IGRAs), there is relatively limited data on association between occupational tuberculosis (TB) risk factors and test ...
Alice Zwerling +9 more
doaj +1 more source
«Interferon Gamma Release Assays» ou IGRA
Bei IGRA handelt es sich um In-vitro-Tests zum Nachweis von spezifischen Effektor-T-Lymphozyten, die nach Sensibilisierung durch Mycobacterium tuberculosis Interferon gamma produzieren.
Minh Khoa Truong +4 more
openaire +1 more source
Objective: To evaluate the performance of interferon gamma release assays and tuberculin skin test in HIV-infected children and adolescents with immune reconstitution.
Keswadee Lapphra +11 more
doaj +1 more source
Interferon Gamma Release Assays in active Tuberculosis: new medical insights
Since first presentation, Interferon γ Release Assays (IGRAs) have had basic and wide application to LTBI, in accordance with international consensus and CDC recommendations, leaving their use in active TB to the field of study and research.We reviewed ...
Sandro Pierdomenico +4 more
doaj +1 more source
A profusion of articles have been published on the accuracy and uses of interferon-gamma releasing assays. Here we review the clinical applications, advantages, and limitations of the tuberculin skin test and interferon-gamma release assays and provide ...
A. Trajman, R. E. Steffen, D. Menzies
doaj +1 more source
Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark.
BackgroundThe QuantiFERON-TB-Gold Test (QFT) is more specific than the Mantoux skin-test to discriminate between Mycobacterium tuberculosis (MTB) and non-tuberculous mycobacterial (NTM) infections.
Thomas Stig Hermansen +3 more
doaj +1 more source
We describe a 34-year-old woman with isolated tuberculosis (TB) uveitis who had unsuccessful resolution of her ocular surface squamous neoplasia after multiple shave excisions with a positive purified protein derivative (PPD) test and interferon-gamma ...
Hossein Aghaei +3 more
doaj +1 more source

